Pathway Background and Objectives
Patients with Intestinal Failure (IF) often require central venous catheter (CVCs) for extended periods of time used for administration of parenteral nutrition (PN), which is required to maintain adequate growth and hydration. This puts them at a risk of recurrent central-line associated bloodstream infections (CLABSIs), with rates being higher than other pediatric patients with central lines.
Bacterial translocation in patients with short bowel syndrome (SBS) is thought to contribute to risk for recurrent CVC infection. Septic complications, related to catheter-related bacteremia and liver failure, are the leading causes of morbidity and mortality in these PN-dependent patients.
There is a research-proven association between time to antibiotics (TTA) to survival in patients with sepsis or septic shock. Therefore, there are many efforts across different institutions to reduce the time to antibiotics (TTA) for these patients.